Integra Lifesciences Holdings Corp (IART)
23.58
+0.58
(+2.52%)
USD |
NASDAQ |
Nov 22, 16:00
23.55
-0.03
(-0.13%)
After-Hours: 20:00
Integra Lifesciences Holdings Cash from Operations (Quarterly): 22.48M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 22.48M |
| June 30, 2024 | 40.40M |
| March 31, 2024 | 15.76M |
| December 31, 2023 | 58.75M |
| September 30, 2023 | 26.77M |
| June 30, 2023 | 28.28M |
| March 31, 2023 | 26.16M |
| December 31, 2022 | 85.33M |
| September 30, 2022 | 68.31M |
| June 30, 2022 | 66.48M |
| March 31, 2022 | 44.34M |
| December 31, 2021 | 69.28M |
| September 30, 2021 | 82.78M |
| June 30, 2021 | 91.29M |
| March 31, 2021 | 69.08M |
| December 31, 2020 | 80.26M |
| September 30, 2020 | 69.64M |
| June 30, 2020 | 33.12M |
| March 31, 2020 | 20.81M |
| December 31, 2019 | 89.18M |
| September 30, 2019 | 64.24M |
| June 30, 2019 | 48.52M |
| March 31, 2019 | 29.48M |
| December 31, 2018 | 42.69M |
| September 30, 2018 | 79.25M |
| Date | Value |
|---|---|
| June 30, 2018 | 36.21M |
| March 31, 2018 | 41.53M |
| December 31, 2017 | 11.55M |
| September 30, 2017 | 45.24M |
| June 30, 2017 | 28.87M |
| March 31, 2017 | 28.88M |
| December 31, 2016 | 6.529M |
| September 30, 2016 | 46.77M |
| June 30, 2016 | 38.08M |
| March 31, 2016 | 25.03M |
| December 31, 2015 | 25.64M |
| September 30, 2015 | 19.61M |
| June 30, 2015 | 27.98M |
| March 31, 2015 | 31.62M |
| December 31, 2014 | 24.86M |
| September 30, 2014 | 31.08M |
| June 30, 2014 | 16.38M |
| March 31, 2014 | 11.25M |
| December 31, 2013 | 11.70M |
| September 30, 2013 | 30.81M |
| June 30, 2013 | 2.918M |
| March 31, 2013 | 7.846M |
| December 31, 2012 | -3.403M |
| September 30, 2012 | 27.91M |
| June 30, 2012 | 2.276M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
15.76M
Minimum
Mar 2024
91.29M
Maximum
Jun 2021
54.43M
Average
62.61M
Median
Cash from Operations (Quarterly) Benchmarks
| Boston Scientific Corp | 1.002B |
| Haemonetics Corp | 48.82M |
| ResMed Inc | 325.54M |
| Globus Medical Inc | 203.65M |
| Perspective Therapeutics Inc | 3.366M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -10.40M |
| Cash from Financing (Quarterly) | -19.92M |
| Free Cash Flow | 38.04M |
| Free Cash Flow Per Share (Quarterly) | -0.0937 |
| Free Cash Flow to Equity (Quarterly) | 11.54M |
| Free Cash Flow to Firm (Quarterly) | 0.3626M |
| Free Cash Flow Yield | 2.08% |